戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1                       Intratumoral heterogeneity in bladder cancer is a barrier to accurate molecular sub-classification
2                                                    Prostate cancer is a heterogeneous cancer with widely varying levels o
3                                                    Prostate cancer is a major cause of cancer morbidity and mortality.
4 al growth factor receptor (EGFR) mutant non-small-cell lung cancer is a persistent challenge in cancer therapy.
5                                  Hereditary diffuse gastric cancer is a rare condition that accounts for approximately 1-
6                                                    Cervical cancer is among the most common preventable cancers with the
7                                          Surgery for rectal cancer is associated with substantial morbidity and mortality
8                                             Invasive breast cancer is believed to evolve from non-invasive ductal carcino
9   Our findings establish that a bacterial immunotherapy for cancer is capable of inducing tumor immunity, an antitumor ef
10                The treatment landscape of advanced prostate cancer is changing rapidly.
11                                                  Pancreatic cancer is characterized by an extensive and complex microenvi
12       Nonadherence to aromatase inhibitors (AIs) for breast cancer is common and increases the risk of recurrence.
13 e demonstrate that the order of driver events in colorectal cancer is determined primarily by the fitness effects that th
14      However, exploiting ctDNA to determine how a patient's cancer is evolving in order to aid clinical decisions remains
15                  The prognosis for patients with pancreatic cancer is extremely poor, as they are resistant to first line
16 ng of hyperpolarized [1-(13)C]pyruvate metabolism in breast cancer is feasible and demonstrated significant intertumoral
17   A significant therapeutic impact on patients with bladder cancer is found in the use of immune checkpoint inhibitor the
18                                         Knowledge of CRC in cancer is fundamental to understanding cancer-specific transc
19                     Prognosis in young patients with breast cancer is generally poor, yet considerable differences in cli
20         The burden of disease and economic impact of breast cancer is intensifying in LMICs.
21  how chronic inflammation leads to the development of colon cancer is lacking.
22    An in-depth understanding of immune escape mechanisms in cancer is likely to lead to innovative advances in immunother
23 he most important emerging aspects of precision medicine in cancer is matching patients and treatments based on the genom
24 the histotype-specific regulation of tumor fibrosis in lung cancer is mediated through differential SMAD3 promoter methyl
25 protection in other diseases, however, its role in prostate cancer is not definitive.
26 nship between use of powder in the genital area and ovarian cancer is not established.
27 uberculosis before immune checkpoint inhibitor treatment in cancer is not routine, despite the increasing number of repor
28 Whether PLK4 inhibitors can be leveraged as a treatment for cancer is not yet clear.
29 merging multidisciplinary field of the physical sciences of cancer is now embraced by engineers, physicists, cell biologi
30                                                      Breast cancer is one of lethal cancers among women with its metastas
31                                                        Lung cancer is one of most common malignancies worldwide.
32 he highest quality of patient care, to create a world where cancer is prevented and every survivor is healthy.
33 complexes as ER stress-inducing agents for the treatment of cancer is provided, along with a summary of structural trends
34                                         Metabolic demand of cancer is quite unique compared to normal tissues and this is
35 r understanding of the complex relationship between age and cancer is still in its infancy(2,3,7,8).
36                                                     Ovarian cancer is the fifth cause of cancer-related mortality in wome
37                                                     Gastric cancer is the fifth most common cancer and the third most com
38                                                  Pancreatic cancer is the fourth leading cause of death worldwide due to
39                                                       Colon cancer is the most aggressive tumor in both men and women glo
40                                                      Breast cancer is the most common cancer, and the second cause of can
41                                                      Breast cancer is the second leading cause of cancer-related death in
42                                                    Prostate cancer is the second most common cancer in men worldwide(1).
43                                                        Lung cancer is the world's leading cause of cancer death and shows
44  technologies as a strategy for earlier detection of breast cancer is thus highly desirable.
45 hanism involved in increasing the numbers of CTCs in breast cancer is unclear.
46 apy in first-line HER2-positive metastatic oesophagogastric cancer is underway.
47  the signaling mechanism that activates p300 in response to cancer is unknown.
48 ng in the absence of heart failure is sufficient to promote cancer is unknown.
49                                     Hitherto, their role in cancer is unknown.
50            Genetic testing for hereditary predisposition to cancer is warranted in UM patients with strong personal or fa